North America Orthobiologic Procedures Count by Segments and Forecast to 2030

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$3995
Buy Report Download FREE Resources

Published: January 13, 2023 Report Code: GDMEPD1219R20-ST

Select Item

North America Orthobiologic Procedures Market Report Overview

The total number of Orthobiologic Procedures in North America was 4,673,444 in 2022. The North America Orthobiologic Procedures market report provides key information and data on procedure volumes for different segments of Orthobiologic Procedures conducted in the country during the historical (2015-2022) and forecast period (2023-2030).

Orthobiologics refers to the use of biological substances to help musculoskeletal injuries heal quicker. They are used to improve the healing of fractured bones and injured muscles, tendons, and ligaments and are derived from substances that are naturally found in the body. Orthobiologics that contain stem cells are those that likely work through their stem cell content.

North America Orthobiologic Procedures Market Segments

The key segments of North America Orthobiologic Procedures market are Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures, Soft Tissue Biologics Procedures, Bone Growth Stimulators Procedures, and Cartilage Repair Procedures. The Bone Grafts and Substitutes Procedures segment accounted for the highest count in 2022. The procedures involve use of bone graft when there is a breakage in the bone or in case of a void between or in the bones due to number of factors such as age and degenerative diseases.

North America Orthobiologic Procedures Market Analysis by Segments, 2022 (%)

North America Orthobiologic Procedures Market Analysis by Segments, 2022 (%)

For more insights on the North America Orthobiologic Procedures market segments, download a free sample report

North America Orthobiologic Procedures Market Segmentation by Country

The key countries in the North America Orthobiologic Procedures market are Canada, Mexico, and the US. The US had the largest number of Orthobiologic Procedures performed in 2022.

North America Orthobiologic Procedures Market Analysis by Country, 2022 (%)

North America Orthobiologic Procedures Market Analysis by Country, 2022 (%)

For more insights on the country analysis of North America Orthobiologic Procedures market, download a free sample report

North America Orthobiologic Procedures Market Overview

Market size (2022) 4,673,444
Historical period 2015-2022
Forecast period 2023-2030
Key segments Bone Grafts and Substitutes Procedures, Viscosupplementation Procedures, Soft Tissue Biologics Procedures, Bone Growth Stimulators Procedures, and Cartilage Repair Procedures
Key countries Canada, Mexico, and the US

Segments Covered in the Report

North America Orthobiologic Procedures Market Segments Outlook (Number of Procedures, 2015-2030)

  • Bone Graft and Substitute Procedures
  • Bone Growth Stimulators Procedures
  • Cartilage Repair Procedures
  • Soft Tissue Biologics Procedures
  • Viscosupplementation Procedures

North America Orthobiologic Procedures Market Country Outlook (Number of Procedures, 2015-2030)

  • Canada
  • Mexico
  • The US

Scope

North America Orthobiologic Procedures is segmented as follows:

• Bone Grafts and Substitutes Procedures

• Bone Growth Stimulators Procedures

• Cartilage Repair Procedures

• Soft Tissue Biologics Procedures

• Viscosupplementation Procedures

Reasons to Buy

North America Orthobiologic Procedures report helps you to develop:

  • Business strategies by identifying the key segments poised for strong growth in the future.

  • Market-entry and market expansion strategies.

  • Develop investment strategies by identifying the key segments expected to register strong growth in the near future.

Table of Contents

  • 1 Introduction

    • 1.1 What Is This Report About?

    • 1.2 Orthobiologic Procedures, Segmentation

    • 1.3 Definitions of Procedures Covered in the Report

  • 2 Orthobiologic Procedures, North America

    • 2.1 Orthobiologic Procedures, North America, 2015-2030

    • 2.2 Orthobiologic Procedures, North America, 2015-2022

  • 3 Orthobiologic Procedures, Canada

    • 3.1 Orthobiologic Procedures, Canada, 2015-2030

      • 3.1.1 Bone Grafts and Substitutes Procedures, Canada, 2015-2030

      • 3.1.2 Bone Growth Stimulators Procedures, Canada, 2015-2030

      • 3.1.3 Cartilage Repair Procedures, Canada, 2015-2030

      • 3.1.4 Soft Tissue Biologics Procedures, Canada, 2015-2030

  • 4 Orthobiologic Procedures, Mexico

    • 4.1 Orthobiologic Procedures, Mexico, 2015-2030

      • 4.1.1 Bone Grafts and Substitutes Procedures, Mexico, 2015-2030

      • 4.1.2 Bone Growth Stimulators Procedures, Mexico, 2015-2030

      • 4.1.3 Cartilage Repair Procedures, Mexico, 2015-2030

      • 4.1.4 Soft Tissue Biologics Procedures, Mexico, 2015-2030

  • 5 Orthobiologic Procedures, United States

    • 5.1 Orthobiologic Procedures, United States, 2015-2030

      • 5.1.1 Bone Grafts and Substitutes Procedures, United States, 2015-2030

      • 5.1.2 Bone Growth Stimulators Procedures, United States, 2015-2030

      • 5.1.3 Cartilage Repair Procedures, United States, 2015-2030

      • 5.1.4 Soft Tissue Biologics Procedures, United States, 2015-2030

  • 6 Appendix

    • 6.1 Research Methodology

      • 6.1.1 Coverage

      • 6.1.2 Secondary Research

      • 6.1.3 Primary Research

      • 6.1.4 Market Modeling and Forecasting

      • 6.1.5 Company Share Analysis

      • 6.1.6 Distribution Share Analysis

      • 6.1.7 Benchmarking

    • 6.2 GlobalData Consulting

    • 6.3 Contact Us

    • 6.4 Disclaimer

Table

List of Tables

Table 1: Orthobiologic Procedures, North America, 2015-2030 9

Table 2: Orthobiologic Procedures, North America, 2015-2022 11

Table 3: Orthobiologic Procedures, North America, 2023-2030 13

Table 4: Orthobiologic Procedures, Canada, 2015-2022 15

Table 5: Orthobiologic Procedures, Canada, 2023-2030 17

Table 6: Bone Grafts and Substitutes Procedures, Canada, 2015-2022 19

Table 7: Bone Grafts and Substitutes Procedures, Canada, 2023-2030 21

Table 8: Bone Growth Stimulators Procedures, Canada, 2015-2022 23

Table 9: Bone Growth Stimulators Procedures, Canada, 2023-2030 25

Table 10: Cartilage Repair Procedures, Canada, 2015-2022 27

Table 11: Cartilage Repair Procedures, Canada, 2023-2030 29

Table 12: Soft Tissue Biologics Procedures, Canada, 2015-2022 31

Table 13: Soft Tissue Biologics Procedures, Canada, 2023-2030 33

Table 14: Orthobiologic Procedures, Mexico, 2015-2022 35

Table 15: Orthobiologic Procedures, Mexico, 2023-2030 37

Table 16: Bone Grafts and Substitutes Procedures, Mexico, 2015-2022 39

Table 17: Bone Grafts and Substitutes Procedures, Mexico, 2023-2030 41

Table 18: Bone Growth Stimulators Procedures, Mexico, 2015-2022 43

Table 19: Bone Growth Stimulators Procedures, Mexico, 2023-2030 45

Table 20: Cartilage Repair Procedures, Mexico, 2015-2022 47

Table 21: Cartilage Repair Procedures, Mexico, 2023-2030 49

Table 22: Soft Tissue Biologics Procedures, Mexico, 2015-2022 51

Table 23: Soft Tissue Biologics Procedures, Mexico, 2023-2030 53

Table 24: Orthobiologic Procedures, United States, 2015-2022 55

Table 25: Orthobiologic Procedures, United States, 2023-2030 57

Table 26: Bone Grafts and Substitutes Procedures, United States, 2015-2022 59

Table 27: Bone Grafts and Substitutes Procedures, United States, 2023-2030 61

Table 28: Bone Growth Stimulators Procedures, United States, 2015-2022 63

Table 29: Bone Growth Stimulators Procedures, United States, 2023-2030 65

Table 30: Cartilage Repair Procedures, United States, 2015-2022 67

Table 31: Cartilage Repair Procedures, United States, 2023-2030 69

Table 32: Soft Tissue Biologics Procedures, United States, 2015-2022 71

Table 33: Soft Tissue Biologics Procedures, United States, 2023-2030 73

Table 34: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 76

Figures

List of Figures

Figure 1: Orthobiologic Procedures, North America, 2015-2030 8

Figure 2: Orthobiologic Procedures, North America, 2015-2022 10

Figure 3: Orthobiologic Procedures, North America, 2023-2030 12

Figure 4: Orthobiologic Procedures, Canada, 2015-2022 14

Figure 5: Orthobiologic Procedures, Canada, 2023-2030 16

Figure 6: Bone Grafts and Substitutes Procedures, Canada, 2015-2022 18

Figure 7: Bone Grafts and Substitutes Procedures, Canada, 2023-2030 20

Figure 8: Bone Growth Stimulators Procedures, Canada, 2015-2022 22

Figure 9: Bone Growth Stimulators Procedures, Canada, 2023-2030 24

Figure 10: Cartilage Repair Procedures, Canada, 2015-2022 26

Figure 11: Cartilage Repair Procedures, Canada, 2023-2030 28

Figure 12: Soft Tissue Biologics Procedures, Canada, 2015-2022 30

Figure 13: Soft Tissue Biologics Procedures, Canada, 2023-2030 32

Figure 14: Orthobiologic Procedures, Mexico, 2015-2022 34

Figure 15: Orthobiologic Procedures, Mexico, 2023-2030 36

Figure 16: Bone Grafts and Substitutes Procedures, Mexico, 2015-2022 38

Figure 17: Bone Grafts and Substitutes Procedures, Mexico, 2023-2030 40

Figure 18: Bone Growth Stimulators Procedures, Mexico, 2015-2022 42

Figure 19: Bone Growth Stimulators Procedures, Mexico, 2023-2030 44

Figure 20: Cartilage Repair Procedures, Mexico, 2015-2022 46

Figure 21: Cartilage Repair Procedures, Mexico, 2023-2030 48

Figure 22: Soft Tissue Biologics Procedures, Mexico, 2015-2022 50

Figure 23: Soft Tissue Biologics Procedures, Mexico, 2023-2030 52

Figure 24: Orthobiologic Procedures, United States, 2015-2022 54

Figure 25: Orthobiologic Procedures, United States, 2023-2030 56

Figure 26: Bone Grafts and Substitutes Procedures, United States, 2015-2022 58

Figure 27: Bone Grafts and Substitutes Procedures, United States, 2023-2030 60

Figure 28: Bone Growth Stimulators Procedures, United States, 2015-2022 62

Figure 29: Bone Growth Stimulators Procedures, United States, 2023-2030 64

Figure 30: Cartilage Repair Procedures, United States, 2015-2022 66

Figure 31: Cartilage Repair Procedures, United States, 2023-2030 68

Figure 32: Soft Tissue Biologics Procedures, United States, 2015-2022 70

Figure 33: Soft Tissue Biologics Procedures, United States, 2023-2030 72

Frequently asked questions

North America Orthobiologic Procedures Count by Segments and Forecast to 2030 standard reports
Currency USD
$3,995

Can be used by individual purchaser only

Most Popular
$7,990

Can be shared by unlimited users within one corporate location e.g. a regional office

$11,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

North America Orthobiologic Procedures Count by Segments and Forecast to 2030 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Orthobiologics reports
Medical Devices
New
Clostridium Difficile Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Medical Devices
New
Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and…
$7,500 | May 2026
Medical Devices
New
Hepatitis B Tests Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | May 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at North America Orthobiologic Procedures Count by Segments and Forecast to 2030 in real time.

  • Access a live North America Orthobiologic Procedures Count by Segments and Forecast to 2030 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more